Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 19

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis

180	Metz, M., Ohanyan, T., Church, M. K.+, and Maurer, M.: Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. J. Dermatol. Sci. 2014: 73; 57-62. IF: 3.42

60	Młynek, A., Zalewska-Janowska, A., Martus, P., Staubach, P., Zuberbier, T., and Maurer, M.+: How to assess disease activity in patients with chronic urticaria? Allergy 2008: 63; 777-780. IF: 6.20

408.	Altrichter, S., Zampeli, V., Ellrich, A., Zhang, K., Church, M. K., and Maurer, M.⁺: IgM and IgA in addition to IgG autoantibodies against FceRIa are frequent and associated with disease markers of chronic spontaneous urticaria. Allergy 2020: 75; 3208-3215. IF: 13.15

o.408

141	Kolkhir, P., Bonnekoh, H., Kocatürk, E., Hide, M., Metz, M., Sanchez-Borges, M., Krause, K. and Maurer, M.+: Management of urticarial vasculitis: a worldwide physician perspective. World Allergy Organ. J. 2018: 11; 14. IF: 3.68

r.141

89	Metz, M., Scholz, E., Ferrán, M., Izquierdo, I., Giménez-Arnau, A., and Maurer, M.+: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann. Allergy Asthma Immunol. 2010: 104; 86-92. IF: 2.80

Management of chronic spontaneous urticaria: a worldwide perspective

312

Kolkhir, P.+, Pogorelov, D., Darlenski, R., Caminati, M., Tanno, L. K., Le Pham, D., Gonzalez-Estrada, A., Antolin-Amérigo, D., Dimov, V., Weller, K., Sanchez-Borges, M., Ansotegui, I., and Maurer, M.: Management of chronic spontaneous urticaria: a worldwide perspective. World Allergy Organ. J. 2018: 11; 14 eCollection. IF: 3.68

o.312

Differences in chronic spontaneous urticaria between Europe and Central/ South America: results of the multi-center real world AWARE study

331

Maurer, M.+, Houghton, K., Costa, C., Dabove, F., Ensina, L. F., Giménez-Arnau, A., Guillet, G., Konstantinou, G. N., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Pastorello, E. A., Velásquez-Lopera, M., Tamayo Quijano, L., M.; Vestergaard, C., and Chapman-Rothe, N.: Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study. World Allergy Organ. J. 2018: 11; 32. IF: 3.68

o.331

Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria

414.

Kolkhir, P., Altrichter, S., Asero, R., Daschner, A., Ferrer, M., Giménez-Arnau, A., Hawro, T., Jakob, T., Kinaciyan, T., Kromminga, A., Konstantinou, G. N. Makris, M., Metz, M., Stahl Skov, P., Staubach, P., Sussman, G., Zhang, K., and Maurer, M.⁺: Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol. Res. 2021: 13; 545-559. IF: 5.10

o.414

439.	Bizjak, M., Maurer, M.⁺, Košnik, M., Terhorst-Molawi, D., Zver, S., Burmeister, T., and Siebenhaar, F.: Severe cold urticaria can point to an underlying clonal mast cell disorder. Allergy 2021: 76; 2609-2613. IF: 14.71

o.439

11.	Maurer, M., Siebenhaar, F., Syska, W., and Magerl, M.: Ätiopathogenese der akuten und der chronischen Urtikaria. Allergo J. 2006: 15; 199-204. IF: N/A